Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2003-2007
Title: **Innovator Jens Schneider-Mergner: Advancements in Optical Diagnosis**
Introduction
Jens Schneider-Mergner, a prominent inventor based in Berlin, Germany, has made significant contributions to the field of medical diagnostics. With two patents to his name, Schneider-Mergner's work focuses on improving optical diagnosis methods, particularly in cancer detection.
Latest Patents
Schneider-Mergner's latest patents highlight the innovative use of short-warp peptide-dye conjugates as contrast agents in optical diagnostics. The first patent presents cyanine dyes and analogs of the vaso-active intestinal peptide, which are utilized to create peptide-dye conjugates for enhanced contrast media in optical diagnoses. The second patent describes compounds for tumor diagnosis, comprising conjugates of dyes with short-chain peptides derived from vaso-active intestinal peptide, somatostatin, or neurotensin. These compounds serve as effective optical diagnostic agents, playing a crucial role in improving the accuracy of tumor detection.
Career Highlights
Throughout his career, Jens Schneider-Mergner has been associated with notable research institutions such as the Institute für Diagnostik Forschung and Institut für Diagnostikforschung GmbH. His work in these organizations has allowed him to develop groundbreaking techniques and contribute to significant advancements in the field of diagnostic research.
Collaborations
Schneider-Mergner has collaborated with esteemed colleagues, including Kai Licha and Andreas Becker. These collaborations have facilitated the exchange of ideas and innovations, fostering an environment of creativity and scientific advancement in their research endeavors.
Conclusion
Jens Schneider-Mergner stands out as a leading inventor in the realm of optical diagnostics. His innovative patents not only advance the potential for more accurate tumor diagnosis but also reflect his dedication to improving medical technology. As the field of diagnostics continues to evolve, Schneider-Mergner's contributions will undoubtedly play a vital role in shaping the future of medical innovation.